Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies. Fortis delivered strong financial performance in 2021 and has significantly scaled its commercial capabilities. Over the course of the last thirteen months, the company has built a portfolio of high-quality products and brands serving attractive end markets including diagnostic, therapeutic and discovery, through its acquisition of four complementary companies: Bethyl Laboratories manufactures premium quality, proprietary antibodies, and custom antibody services for the life sciences industry. nanoComposix specializes in ultra-sensitive, quantitative lateral flow diagnostic assays, producing nanoparticles and offering custom assay development and contract manufacturing services. Empirical Bioscience produces assay-grade molecular biology enzymes exclusively for diagnostic and commercial assay customers. Arista Biologicals manufactures antibodies and other immunodiagnostic reagents for rapid testing assays used in drugs of abuse, infectious diseases, and fertility testing.